North America Healthcare Analytics Market Size

North America Healthcare Analytics Market Analysis

The North America Healthcare Analytics Market size is estimated at USD 18.88 billion in 2024, and is expected to reach USD 53.46 billion by 2029, growing at a CAGR of 23.14% during the forecast period (2024-2029).

The outbreak of the COVID-19 virus has had a predominant effect on the economics and business of major countries of the world. Because of the outbreak, there has been a rise in the significance of big data in the healthcare sector. The prescriptive and predictive analytics solutions have been used to create prediction models to assess the advent of following waves of COVID-19 infection spread in various countries of the world. The rise in the acceptance of electronic health records in developed and developing nations during the pandemic has further fueled the expansion of the market in 2020. For instance, in 2021 an article titled, 'Health Analytics on COVID-19 Data with Few-Shot Learning' reported that health analytics tools can lead to the discovery of useful information and knowledge about diseases such as the coronavirus disease 2019 (COVID-19) and related diseases. This knowledge helps users to get a better understanding of the disease, and thus take part in preventing, controlling, and/or combating the disease.

The factors that drive the North American healthcare analytics market are favorable healthcare policies, the emergence of big data in the healthcare industry, and technological advancements accelerating market growth. The favorable healthcare policies in the region are another region to drive the healthcare analytics market. For instance, in 2022 an article titled 'The Affordable Care Act After a Decade: Its Impact on the Labor Market and the Macro Economy' reported that maturing value-based payment models, more than a decade since the passage of the Affordable Care Act in the United States, continue to create openings for companies that reimagine care delivery with a focus on patient experience, health outcomes, and costs. Also, the pandemic has accelerated the use of digital tools that use big data and machine learning in every health sector, helping to make many operations more efficient and spur innovation. The result could be better health outcomes at a lower cost.

With the recent global pandemic of COVID-19, there need to be strategies to treat this health pandemic. For instance, in 2020 an article titled, 'Big data analytics as a tool for fighting pandemics: a systematic review of the literature' reported that the adoption of big data, as well as big data analytics techniques, have been addressed in this context with the possibility of predicting, mapping, tracking, monitoring, and raising awareness about these epidemics and pandemics. For the collection and analysis of data, the software NVivo 12 and VOSviewer were used. The content analysis sought to identify how big data and big data analytics can help fight epidemics and pandemics. The types and sources of data used in cases of previous epidemics and pandemics were identified, as well as techniques for treating these data. Thus, the use of such technologies is driving the market in the region.

Therefore, due to the above-mentioned factors, the market is expected to show significant growth over the forecast period. However, lack of skilled personnel, data integrity, security issues, and the cost and complexity of software may slow down the growth of the market.